Elena Navarro-Guerrero

Prof. Elena Navarro-Guerrero

University of Oxford, UK
+1
orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2017 in Cell Reports
Verified
Journal Article
Open access
VAValentina Annese
Valentina Annese
ENElena Navarro-Guerrero
Elena Navarro-Guerrero
IRIsmael Rodríguez-Prieto
Ismael Rodríguez-Prieto
RPRicardo Pardal
Ricardo Pardal
Adult stem cell plasticity, or the ability of somatic stem cells to cross boundaries and differentiate into unrelated cell types, has been a matter of debate in the last decade. Neural-crest-derived stem cells (NCSCs) display a remarkable plasticity during development. Whether adult populations of NCSCs retain this plasticity is largely unknown. Herein, we describe that neural-crest-derived adult carotid body stem cells (CBSCs) are able to undergo endothelial differentiation in addition to their reported role in neurogenesis, contributing to both neurogenic and angiogenic processes taking place in the organ during acclimatization to hypoxia. Moreover, CBSC conversion into vascular cell types is hypoxia inducible factor (HIF) dependent and sensitive to hypoxia-released vascular cytokines such as erythropoietin. Our data highlight a remarkable physiological plasticity in an adult population of tissue-specific stem cells and could have impact on the use of these cells for cell therapy.

1 September 2020 in Molecular Cell
Verified
Journal Article
Open access
MWMichael L. van de Weijer
Michael L. van de Weijer
LKLogesvaran Krshnan
Logesvaran Krshnan
SLSabrina Liberatori
Sabrina Liberatori
ENElena Navarro-Guerrero
Elena Navarro-Guerrero
JRJacob Robson-Tull
Jacob Robson-Tull
PCPedro Carvalho
Pedro Carvalho
Misfolded proteins in the endoplasmic reticulum (ER) are degraded by ER-associated degradation (ERAD). Although ERAD components involved in degradation of luminal substrates are well characterized, much less is known about quality control of membrane proteins. Here, we analyzed the degradation pathways of two short-lived ER membrane model proteins in mammalian cells. Using a CRISPR-Cas9 genome-wide library screen, we identified an ERAD branch required for quality control of a subset of membrane proteins. Using biochemical and mass spectrometry approaches, we showed that this ERAD branch is defined by an ER membrane complex consisting of the ubiquitin ligase RNF185, the ubiquitin-like domain containing proteins TMUB1/2 and TMEM259/Membralin, a poorly characterized protein. This complex cooperates with cytosolic ubiquitin ligase UBE3C and p97 ATPase in degrading their membrane substrates. Our data reveal that ERAD branches have remarkable specificity for their membrane substrates, suggesting that multiple, perhaps combinatorial, determinants are involved in substrate selection.

19 February 2021 in Scientific Reports
Verified
Journal Article
Open access
PDF file
ENElena Navarro-Guerrero
Elena Navarro-Guerrero
CTChwen Tay
Chwen Tay
JWJustin P. Whalley
Justin P. Whalley
SCSally A. Cowley
Sally A. Cowley
BDBen Davies
Ben Davies
DEDaniel Ebner
Daniel Ebner
Genome engineering using CRISPR/Cas9 technology enables simple, efficient and precise genomic modifications in human cells. Conventional immortalized cell lines can be easily edited or screened using genome-wide libraries with lentiviral transduction. However, cell types derived from the differentiation of induced Pluripotent Stem Cells (iPSC), which often represent more relevant, patient-derived models for human pathology, are much more difficult to engineer as CRISPR/Cas9 delivery to these differentiated cells can be inefficient and toxic. Here, we present an efficient, lentiviral transduction protocol for delivery of CRISPR/Cas9 to macrophages derived from human iPSC with efficiencies close to 100%. We demonstrate CRISPR/Cas9 knockouts for three nonessential proof-of-concept genes—HPRT1, PPIBandCDK4. We then scale the protocol and validate for a genome-wide pooled CRISPR/Cas9 loss-of-function screen. This methodology enables, for the first time, systematic exploration of macrophage involvement in immune responses, chronic inflammation, neurodegenerative diseases and cancer progression, using efficient genome editing techniques.

11 February 2016 in Stem Cells
Verified
Journal Article
Open access
PDF file
ENElena Navarro-Guerrero
Elena Navarro-Guerrero
APAida Platero-Luengo
Aida Platero-Luengo
PLPedro Linares-Clemente
Pedro Linares-Clemente
ICIldefonso Cases
Ildefonso Cases
JLJosé López-Barneo
José López-Barneo
RPRicardo Pardal
Ricardo Pardal
Neural stem cells (NSCs) are promising tools for understanding nervous system plasticity and repair, but their use is hampered by the lack of markers suitable for their prospective isolation and characterization. The carotid body (CB) contains a population of peripheral NSCs, which support organ growth during acclimatization to hypoxia. We have set up CB neurosphere (NS) cultures enriched in differentiated neuronal (glomus) cells versus undifferentiated progenitors to investigate molecular hallmarks of cell classes within the CB stem cell (CBSC) niche. Microarray gene expression analysis in NS is compatible with CBSCs being neural crest derived‐multipotent progenitor cells able to sustain CB growth upon exposure to hypoxia. Moreover, we have identified CD10 as a marker suitable for isolation of a population of CB mesectoderm‐committed progenitor cells. CD10 + cells are resting in normoxia, and during hypoxia they are activated to proliferate and to eventually complete maturation into mesectodermal cells, thus participating in the angiogenesis necessary for CB growth. Our results shed light into the molecular and cellular mechanisms involved in CBSC fate choice, favoring a potential use of these cells for cell therapy. Stem Cells 2016;34:1637–1650

8 October 2019 in Wellcome Open Research
Verified
Journal Article
Open access
PDF file
AGAntje K. Grotz
Antje K. Grotz
FAFernando Abaitua
Fernando Abaitua
ENElena Navarro-Guerrero
Elena Navarro-Guerrero
BHBenoit Hastoy
Benoit Hastoy
DEDaniel Ebner
Daniel Ebner
AGAnna Gloyn
Anna Gloyn
Type 2 diabetes (T2D) is a global pandemic with a strong genetic component, but most causal genes influencing the disease risk remain unknown. It is clear, however, that the pancreatic beta cell is central to T2D pathogenesis. In vitro gene-knockout (KO) models to study T2D risk genes have so far focused on rodent beta cells. However, there are important structural and functional differences between rodent and human beta cell lines. With that in mind, we have developed a robust pipeline to create a stable CRISPR/Cas9 KO in an authentic human beta cell line (EndoC-βH1). The KO pipeline consists of a dual lentiviral sgRNA strategy and we targeted three genes (INS, IDE, PAM) as a proof of concept. We achieved a significant reduction in mRNA levels and complete protein depletion of all target genes. Using this dual sgRNA strategy, up to 94 kb DNA were cut out of the target genes and the editing efficiency of each sgRNA exceeded >87.5%. Sequencing of off-targets showed no unspecific editing. Most importantly, the pipeline did not affect the glucose-responsive insulin secretion of the cells. Interestingly, comparison of KO cell lines for NEUROD1 and SLC30A8 with siRNA-mediated knockdown (KD) approaches demonstrate phenotypic differences. NEUROD1-KO cells were not viable and displayed elevated markers for ER stress and apoptosis. NEUROD1-KD, however, only had a modest elevation, by 34%, in the pro-apoptotic transcription factor CHOP and a gene expression profile indicative of chronic ER stress without evidence of elevated cell death. On the other hand, SLC30A8-KO cells demonstrated no reduction in KATP channel gene expression in contrast to siRNA silencing. Overall, this strategy to efficiently create stable KO in the human beta cell line EndoC-βH1 will allow for a better understanding of genes involved in beta cell dysfunction, their underlying functional mechanisms and T2D pathogenesis.

1 October 2020 in Molecular Cell
Verified
Journal Article
Open access
MWMichael L. van de Weijer
Michael L. van de Weijer
LKLogesvaran Krshnan
Logesvaran Krshnan
SLSabrina Liberatori
Sabrina Liberatori
ENElena Navarro-Guerrero
Elena Navarro-Guerrero
JRJacob Robson-Tull
Jacob Robson-Tull
PCPedro Carvalho
Pedro Carvalho